Simplify Propel Opportunities ETF Rating $18.71 -0.52 (-2.70%) Closing price 09/23/2026 04:10 PM EasternExtended Trading$18.72 +0.01 (+0.03%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.58Holdings in SURI have an aggregate rating of Moderate Buy based on 185 analyst ratings issued in the past year covering 21 companies (89.8% of the portfolio).SURI Aggregate Price Target$18.71High Prediction$18.71Average Prediction$18.71Low Prediction$18.71Holdings in SURI have an aggregate price target of $18.71 and a range of $18.71 to $18.71 covering 21 companies (89.8% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SURI Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings42.22%PAGPPlains GP$26.69-0.7%Hold$24.91 -6.7%132.9527 of 5 starsDividend AnnouncementAnalyst Forecast13.71%ACHVAchieve Life Sciences$7.83-3.6%Buy$15.00 91.6%82.7546 of 5 stars4.36%DCTHDelcath Systems$15.96-2.7%Moderate Buy$23.17 45.2%73.0878 of 5 stars3.68%MISTMilestone Pharmaceuticals$0.86-6.4%Moderate Buy$6.40 642.5%72.4601 of 5 stars3.10%CORTCorcept Therapeutics$112.94-3.9%Moderate Buy$138.17 22.3%83.8661 of 5 stars2.55%COLLCollegium Pharmaceutical$22.45-1.4%Moderate Buy$48.71 117.0%93.2847 of 5 starsAnalyst Forecast2.24%PHATPhathom Pharmaceuticals$6.99-9.9%Moderate Buy$21.25 204.0%92.7937 of 5 starsNews Coverage2.08%CMPSCompass Pathways$13.75-7.0%Moderate Buy$23.36 69.9%172.3888 of 5 stars1.85%ABEOAbeona Therapeutics$5.53-5.0%Moderate Buy$21.00 279.7%52.8235 of 5 stars1.70%CABACabaletta Bio$2.22-11.2%Moderate Buy$15.33 590.7%82.2194 of 5 stars1.60%OBIOOrchestra BioMed$5.93-4.7%Moderate Buy$13.17 122.0%73.2753 of 5 stars1.56%KYTXKyverna Therapeutics$7.07-5.9%Moderate Buy$30.00 324.3%51.4625 of 5 starsNews CoverageAnalyst Forecast1.54%AQSTAquestive Therapeutics$4.70-5.1%Moderate Buy$9.17 95.0%82.2147 of 5 starsGap Up1.42%IVAInventiva$3.45-5.5%Buy$15.75 356.5%112.6046 of 5 starsUpcoming Earnings1.22%LONAAthira Pharma$5.89-2.6%Moderate Buy$17.33 194.3%62.3621 of 5 starsGap Up1.05%ARTVArtiva Biotherapeutics$7.72-4.6%Moderate Buy$39.00 405.2%63.2989 of 5 starsNews Coverage0.99%CLDXCelldex Therapeutics$31.12-7.1%Moderate Buy$61.92 99.0%142.1894 of 5 starsTrending NewsAnalyst ForecastGap UpHigh Trading Volume0.97%OCULOcular Therapeutix$10.00-4.8%Moderate Buy$25.75 157.5%133.0198 of 5 stars0.83%PALIPalisade Bio$1.60-5.3%Buy$9.83 514.6%102.7445 of 5 starsNews CoveragePositive NewsAnalyst Forecast0.72%PROKProKidney$1.65-9.8%Moderate Buy$12.00 627.3%31.7843 of 5 starsGap Up0.44%SABSSAB Biotherapeutics$3.39-3.1%Moderate Buy$12.00 254.0%112.007 of 5 stars This page (NYSEARCA:SURI) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
